Cargando…

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression

Detalles Bibliográficos
Autores principales:	Maixnerova, Dita, Ling, Chunyan, Hall, Stacy, Reily, Colin, Brown, Rhubell, Neprasova, Michaela, Suchanek, Miloslav, Honsova, Eva, Zima, Tomas, Novak, Jan, Tesar, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625724/ https://www.ncbi.nlm.nih.gov/pubmed/31299057 http://dx.doi.org/10.1371/journal.pone.0219947

Ejemplares similares

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study
por: Neprasova, Michaela, et al.
Publicado: (2016)

Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation
por: Maixnerova, Dita, et al.
Publicado: (2021)

The coincidence of IgA nephropathy and Fabry disease
por: Maixnerová, Dita, et al.
Publicado: (2013)

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
por: Placzek, William J., et al.
Publicado: (2018)

Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis
por: Suzuki, Hitoshi, et al.
Publicado: (2019)

Emerging Modes of Treatment of IgA Nephropathy
por: Maixnerova, Dita, et al.
Publicado: (2020)

Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
por: Neprasova, Michaela, et al.
Publicado: (2023)

Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
por: Reily, Colin, et al.
Publicado: (2014)

Expanding options of supportive care in IgA nephropathy
por: Maixnerova, Dita, et al.
Publicado: (2023)

Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients
por: Reily, Colin, et al.
Publicado: (2018)

Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy
por: Eison, T. Matthew, et al.
Publicado: (2012)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy
por: Reily, Colin, et al.
Publicado: (2022)

Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls
por: Sanders, John T., et al.
Publicado: (2017)

Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
por: Hastings, M. Colleen, et al.
Publicado: (2012)

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
por: Zhao, Na, et al.
Publicado: (2012)

Transient IgA, steady IgG?
por: Berthold, Dorothée L., et al.
Publicado: (2020)

ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy
por: Liu, Youxia, et al.
Publicado: (2019)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Jin Sug, et al.
Publicado: (2020)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
por: Knoppova, Barbora, et al.
Publicado: (2016)

Clinical and Immunological Study of 30 Cases With Both IgG and IgA Anti-Keratinocyte Cell Surface Autoantibodies Toward the Definition of Intercellular IgG/IgA Dermatosis
por: Hashimoto, Takashi, et al.
Publicado: (2018)

Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
por: Nakata, Junichiro, et al.
Publicado: (2014)

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy
por: Yasutake, Junichi, et al.
Publicado: (2015)

Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy
por: Wada, Yukihiro, et al.
Publicado: (2018)

Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy
por: Irabu, Hitoshi, et al.
Publicado: (2020)

Helicobacter pylori infection is associated with elevated galactose-deficient IgA1 in IgA nephropathy
por: Liu, Xing-Zi, et al.
Publicado: (2020)

Clinical Significance of the Intensity of Glomerular Galactose-Deficient IgA1 Deposition in IgA Nephropathy
por: Nakayama, Maiko, et al.
Publicado: (2022)

cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy
por: Misaki, Taro, et al.
Publicado: (2023)

Urine proteomics for prediction of disease progression in patients with IgA nephropathy
por: Rudnicki, Michael, et al.
Publicado: (2020)

Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
por: Liu, Youxia, et al.
Publicado: (2022)

IgG deposition in IgA nephropathy patients
por: Nasri, Hamid
Publicado: (2013)

Linear IgA and IgG bullous dermatosis
por: Fernandes, Karina de Almeida Pinto, et al.
Publicado: (2016)

Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy
por: Sparding, Nadja, et al.
Publicado: (2023)

Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Min Jeong, et al.
Publicado: (2016)

Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG
Publicado: (1985)

New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies
por: Maixnerova, Dita, et al.
Publicado: (2022)

Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis
por: Sparding, Nadja, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0f4fkfh9kf11ram43itu6e22ja